Benghazi – A specialized scientific session took place in Benghazi. It focused on the latest techniques for early detection of latent tuberculosis. Rafea Al-Wadani supervised the session. He is the Executive Director of the Libyan Laboratories Medicine Syndicate in Benghazi. Specialists and professionals in medical laboratories and diagnostics attended.
The session was part of the MEENA 2026 exhibition. Benghazi hosted the exhibition last week. It introduced the “VIDAS 3” device. This is the latest global system for detecting latent tuberculosis. It uses fluorescence enzyme immunoassay technology. This modern technique relies on precise immunoassay. It detects latent tuberculosis infection.
The session highlighted early detection of latent TB. This is especially important for high-risk groups. These include healthcare workers. Direct contacts of infected individuals also benefit. The screening is also used in immigration programs. It is used in international medical examinations.
Attendees reviewed the device’s technical advantages. It provides high-speed results. It offers full automation. The system reduces human error. It has high accuracy and sensitivity in diagnosing latent TB. It minimizes inconclusive results compared to traditional techniques. The device is also easy to use in modern laboratories.
Al-Wadani presented recent global studies. These evaluated the latent TB detection test. The studies included 1,969 people. Participants were from seven countries. They were tested in nine research centers. Results showed the device’s effectiveness. It detects latent TB infection. It achieved high sensitivity, reaching 97.5% in some confirmed cases. The device also showed excellent agreement. It had high specificity compared to competing tests.
Al-Wadani stressed the importance of these sessions. They aim to bring the latest global diagnostic technologies to Libya. They also enhance the efficiency of medical laboratories. This aligns with modern developments in early detection. The focus is on infectious diseases, particularly latent TB.
The session also featured scientific discussions. These explored the future of modern immunoassay technologies. They addressed integrating advanced systems into Libyan laboratories. This includes advanced screening centers. Attendees concluded by emphasizing the need for advanced laboratory solutions. They called for global technologies. This will support the medical laboratories sector. It will raise diagnostic standards across the country.